A Study to Evaluate the Palatability of a Nutritional Support Biscuit (Fitabisc)

Study Overview
=================
Brief Summary
-----------------
A study to evaluate the palatability of a nutritional support biscuit (Fitabisc) in patients about to undergo colorectal surgery.

Detailed Description
-----------------
The question of preoperative supplementation raises another issue about how this might be provided for patients, especially at home. The Chief Investigator has formulated a new biscuit 'Fitabisc' that contains the key antioxidants; vitamins C and E, selenium and glutamine. The advantage of a biscuit is that all ingredients of interest are combined within the one item and so this may be easier for patients to 'take' than other types of supplement. A survey involving 17 community pharmacies in England and Northern Ireland found that 60% of patients aged 60 - 89 years had difficulty swallowing tablets and capsules. The consistency of the biscuit is softer than traditional shortbread and crumbs readily which we hope will make it easy to eat. The aim of this study is to test the palatability of Fitabisc and whether patients undergoing abdominal surgery can eat it in the desired quantities for 10 days before they are admitted to hospital. In summary, most studies to date have looked perioperative or postoperative supplementation with antioxidants alone. No attempt has been made to do this using a palatable biscuit that would facilitate preoperative oral supplementation. If this study confirms the palatability of the biscuit and there is adherence to eating it then it would be our intention to set up a prospective randomized study in which the potential efficacy of Fitabisc would be evaluated.

Official Title
-----------------
A Study to Evaluate the Palatability of a Nutritional Support Biscuit (Fitabisc)

Conditions
-----------------
Colorectal Surgery

Intervention / Treatment
-----------------
* Dietary Supplement: Fitabisc


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients between the ages of 16 and 80 years inclusive. Patients who are having colorectal surgery. Patients who are able to give voluntary, written informed consent to participate in the study and from whom written consent has been obtained. Exclusion Criteria: Those who cannot or do not provide informed consent Patients with a known or suspected allergy to any of the ingredients of Fitabisc e.g. gluten or dairy products Patients with one of the following co-morbidities: Haemochromatosis Thalassaemia Kidney disease Liver disease Reye syndrome Patients who already take supplements of vitamin C, E, selenium or glutamine. Patients with type 1 diabetes, or type 2 diabetes that requires them to have insulin or a hypoglycaemic drug such as Metformin.

Ages Eligible for Study
-----------------
Minimum Age: 16 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Intervention/Treatment |
| --- |
|Dietary Supplement: Fitabisc|Fitabisc is a chocolate cookie with vanilla cream filling which contains the most important antioxidants Vitamin C, Vitamin E, and the mineral Selenium. Fitabisc is not commercially available and for the purposes of this study it will be manufactured by Calerrific Ltd, which already produces a biscuit called CalBisc 100 as a simple calorie and nutritional supplement. Production takes place in a BRC Global Standard Grade A certified bakery operated by Farringford Foods in Portadown, Northern Ireland.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Adherence to dose | Patients to keep a diary of their consumption | 10 days | 
| Palatability of biscuit | Study will measure palatability on a standard Likert scale after 10 days | 10 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Progress of patients following surgery | Adverse event collection - via patient reported outcomes and review of patient notes following surgery | 4-6 weeks post op. | 
| Collection of events that might be associated with the ingredients of the biscuit. | Adverse event collection - via patient reported outcomes and review of patient notes following surgery | 4-6 weeks post op. |